Revel Pharmaceuticals
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2325 3rd St, San Francisco, California, ...Phone Number
(217) 766-4292Website
www.revelpharmaceuticals.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Revel Pharmaceuticals
Revel Pharmaceuticals is a biotechnology company located in San Francisco, CA. with a technology platform based on the work of Yale Professors David Spiegel and Jason Crawford. The company is commercializing therapeutic designer enzymes to degrade molecular damage that accumulates with aging. By addressing one of the hallmarks of aging, Revel is strategically positioned to develop therapeutics for multiple diseases of aging including osteoarthritis, kidney disease, cardiovascular disease, skin aging, and complications of diabetes.Explore more
Revel Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Revel Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Revel Pharmaceuticals has new funding data
Earning: See what the market has to say on Revel Pharmaceuticals recently announced quarterly report
Revel Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Revel Pharmaceuticals is spiking on competitors!
Click to see if Revel Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Revel Pharmaceuticals
Product Launch: Get notified when Revel Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Revel Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Revel Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Revel Pharmaceuticals
Compare insights from companies similar to Revel Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Revel Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Revel Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Revel Pharmaceuticals.
Revel Pharmaceuticals financials insights
Gather financial insights about Revel Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$8.4M
Revel Pharmaceuticals Tech Stack
A closer look at the technologies used by Revel Pharmaceuticals
Most Recent Scoops
Person-Based
Bioengineering, Medical Research
Person-Based
Proof of Concept (POC), Bioengineering
Person-Based
Research & Development, Bioengineering, Medical Research
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Revel Pharmaceuticals News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Revel Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Revel Pharmaceuticals is a biotechnology company located in San Francisco, CA. with a technology platform based on the work of Yale Professors David Spiegel and Jason Crawford. The company is commercializing therapeutic designer enzymes to degrade molecular damage that accumulates with aging. By addressing one of the hallmarks of aging, Revel is st... Read More
